Clinical Trials Logo

Clinical Trial Summary

Abscesses and anal fistulas represent about 70% of perianal suppuration, with an estimated incidence of 1/10,000 inhabitants per year and representing 5% of queries in coloproctology.

Anal fistula is the chronic phase of anorectal infection is characterized by chronic purulent drainage or cyclic pain associated with acute relapse of the abscess followed by intermittent spontaneous decompression.

Perianal fistulas have a troublesome pathology. The most widely accepted theory is that anal abscess is caused by infection of an anal crypt gland. Suppuration moves from the anal gland to the inter-sphincteric space, forming an abscess leading to the development of a fistula. The incidence of fistula following an abscess is nearly 33%.

A fistula can cause pain, perianal swelling, discharge, bleeding, and other nonspecific symptoms.

The diagnosis of fistula-in-ano may include a digital rectal examination, endoanal ultrasound, fistulography, and MRI.

The management of the disease is difficult and sometimes a challenge for the surgeon.

The ideal treatment is based on three central principles: control of sepsis, closure of the fistula and maintenance of continence.

The management of complex fistulas needs to balance the outcomes of cure and continence. Success is usually determined by identification of the primary opening and dividing the least amount of muscle as possible.

There is a risk of sphincter muscle damage during fistulotomy, which can lead to an unacceptable risk of anal incontinence of varying degrees.

The surgical techniques described for the treatment of fistula-in-ano are fistulotomy, core-out fistulectomy, seton placement, endorectal advancement flap, injection of fibrin glue, insertion of a fistula plug, video-assisted anal fistula treatment (VAAFT) and ligation of the intersphincteric fistula tract (LIFT), Surgical techniques are composed of 2 broad categories, including sphincter sacrificing procedures, such as, fistulotomy, fistulectomy and cutting seton. and sphincter-preserving procedures, such as fibrin glue injection, fistula plug, rectal advancement flap, VAAFT and LIFT. In general, sphincter sacrificing procedures have high success rates but are associated with high rates of fecal incontinence. In contrast, sphincter-preserving procedures have more modest success rates but are associated with a relatively minimal risk of changes in continence.

While low transsphincteric fistulae are well-addressed by fistulotomy (i.e., lay-open technique) with minimal change in long-term bowel habits, fistulae which involve more than 30 % of the internal sphincter carry a substantial risk of fecal incontinence with this approach.

Endorectal advancement flap is technically difficult and associated with high recurrence rate up to 50% and risk of incontinence up to 35%.

Fibrin glue and anal fistula plug have a little effect on incontinence but are associated with high recurrence up to 60 % and are costive.

VAAFT is effective method but is highly costive.

Setons can be employed as cutting and non-cutting kinds as dividers or markers . A few types of setons used are the Ayurveda-medicated thread , braided sutures thread, rubber band , Penrose drains and cable tie seton . Seton material should be non-absorbable, from non-slippage material, comfortable and least irritant for the patient and equally ejective in causing focal reaction in the track, leading to fibrosis .

However, setons may cause patient discomfort, both from irritation and from persistent drainage. In addition the incontinence rate may reach 67%.

The ligation of intersphincteric fistula tract (LIFT) was first described by Rojanasakul and colleagues in 2007. Since then, this technique has become popular among providers due to its simple technical elements, particularly when compared to anorectal advancement flaps, and favorable success rate. Among the many studies published in the literature, the success rate after LIFT ranges from 40 to 95 %, with a recurrence rate of 6-28 % .3,5-28 In comparison, success after advancement flap ranges from 60 to 94 %.


Clinical Trial Description

This study is a prospective study;

B) Methodology:

Patients will be classified into two groups according to the surgical procedure performed as follows:

- Group A: Patients undergoing cutting Seton.

- Group B: Patients undergoing LIFT technique.

Aim OF THE STUDY:

To compare between Seton and LIFT technique in management of anal fistula according to ;

1-Feasibility of the technique. 3-Postoperative pain and use of analgesia. 4-Healing time. 5-Recurrence rate. 6-Occurrence of fecal incontinence. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03311035
Study type Interventional
Source Assiut University
Contact Abanoub hosny, MBBCh
Phone 0201019341572
Email abanob.hosni55555@gmail.com
Status Not yet recruiting
Phase N/A
Start date October 18, 2017
Completion date December 30, 2019

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06092398 - Role of Autologous Platelet Rich Plasma(PRP) Injection and Platelet Rich Fibrin Glue(PRFG) Interposition for Treatment of Anal Fistula N/A
Active, not recruiting NCT06243302 - Anal Fistulae Internal Opening Closure by OTSC Clip After Video Assisted Tract Fulguration
Terminated NCT02423330 - A Prospective Evaluation of the Strattice-LIFT to Treat Anal Fistula Early Phase 1
Completed NCT01012843 - Do Antibiotics Prevent Anal Fistulae Formation? N/A
Recruiting NCT04750499 - Treatment of Perianal Fistulas by Endorectal Advancement Flap Associated With Adipose Tissue Injection N/A
Not yet recruiting NCT04541238 - Imaging Template for Reporting Anal Fistula
Recruiting NCT05044182 - Decompression and Drainage Seton for Treatment of High Horseshoe Anal Fistula N/A
Recruiting NCT03690934 - Treatment of Transsphicteric Fistula-in-ano by Method of Laser Thermoobliteration(FiLaC™). N/A
Recruiting NCT01388257 - Anal Crohn Fistula Surgery N/A
Active, not recruiting NCT00115466 - Autologous Stem Cells Derived From Lipoaspirates for the Non-Surgical Treatment of Complex Perianal Fistula Phase 2
Recruiting NCT04790123 - Adipose Tissue Injection for the Treatment of Complex Cryptoglandular Perianal Fistula N/A
Completed NCT05605080 - Hemostatic and Analgesic Effect of Gel Foam and Gauze With Bosmin After Anal Surgery N/A
Recruiting NCT04119700 - Fistulectomy and Primary Sphincter rEconstruction vs. endorectaL Advancement Flap in the Treatment of High Anal Fistulas N/A
Recruiting NCT01997645 - Surgical Treatment of High Perianal Fistulas N/A
Terminated NCT01584752 - Gore-BioA Fistula Plug to Treat Transsphincteric Fistulas
Completed NCT04811105 - INVESTIGATION OF THE EFFICACY OF FISTULA OBLITERATION BY STEAM ABLATION IN PERİANAL FISTULAS N/A
Not yet recruiting NCT05476146 - Re-routing in Treatment High Anal Fistula N/A
Recruiting NCT04616911 - Rerouting Seton Versus LIFT for Complex Anal Fistula N/A
Completed NCT03345511 - Ultrasound Guided Caudal Block for Benign Anal Surgery N/A
Active, not recruiting NCT01931371 - Anal Fistula Plug Versus Endorectal Advancement Flap N/A